Study of Tissue Samples From Patients With Non-Small Cell Lung Cancer
RATIONALE: Studying samples of tissue from patients with cancer in the laboratory may help doctors learn more about changes that occur in DNA and identify biomarkers related to cancer. PURPOSE: This research trial studies tissue samples from patients with non-small cell lung cancer.
Checked against the public recordLast updated Jun 27, 2017 · Source: ClinicalTrials.gov
What this study is about
- Purpose
- Not specified
- Study type
- Observational
- Phase
- Not applicable
- Sponsor
- Alliance for Clinical Trials in Oncology
- Interventions being studied
- Genetic: DNA analysis; Genetic: DNA methylation analysis; Genetic: RNA analysis; Genetic: gene expression analysis; Genetic: polymorphism analysis; Other: laboratory biomarker analysis; Other: medical chart review
How this study is categorized
These labels come from structured fields and exact terms in the public record.
Who may be able to participate
* Patient must have been registered to CALGB 140202. * Tumor histology should be either primary adenocarcinoma or squamous cell carcinoma of the lung. * Patients are eligible for this study if their samples from CALGB 140202 are available. * All living patients must sign the CALGB 151107 consent form to be eligible for this trial.
Important: This is the sponsor’s public criteria, not a determination of eligibility. The study team must review your individual situation.
U.S. locations
- Samuel Oschin Comprehensive Cancer Institute at Cedars-Sinai Medical CenterLos Angeles, California
- Tunnell Cancer Center at Beebe Medical CenterLewes, Delaware
- CCOP - Christiana Care Health ServicesNewark, Delaware
- Greenebaum Cancer Center at University of Maryland Medical CenterBaltimore, Maryland
- Union Hospital of Cecil CountyElkton, Maryland
- Siteman Cancer Center at Barnes-Jewish Hospital - Saint LouisSt Louis, Missouri
- Cancer Institute of New Jersey at Cooper - VoorheesVoorhees Township, New Jersey
- Roswell Park Cancer InstituteBuffalo, New York
- Duke Cancer InstituteDurham, North Carolina
- Rhode Island Hospital Comprehensive Cancer CenterProvidence, Rhode Island
- Miriam HospitalProvidence, Rhode Island
Source and freshness
Processed from ClinicalTrials.gov. Last public update: Jun 27, 2017. Always confirm current availability with the study team.